Latest Cancer News

FDA Approves Polatuzumab Vedotin-Piiq for Diffuse Large B-Cell Lymphoma (06-25-2019)
​The FDA granted accelerated approval to polatuzumab vedotin-piiq, a CD79b-directed antibody-drug conjugate indicated in combination with bendamustine and a rituximab product for adult patients with... Continue Reading

FDA Approves Keytruda for Small Cell Lung Cancer (06-18-2019)
The  Food and Drug Administration granted accelerated approval to Keytruda (pembrolizumab) for patients with metastatic small cell lung cancer (SCLC) with disease progression on or after platinum-based... Continue Reading

FDA Approves Keytruda for First-line Treatment of Head and Neck Squamous Cell Carcinoma (06-13-2019)
FDA approves Keytruda for the first-line treatment of patients with metastatic or unresectable recurrent head and neck squamous cell carcinoma (HNSCC). Keytruda was approved for use in combination with... Continue Reading

More Cancer News

Locations

Montana Cancer Center
500 West Broadway
Missoula, Montana 59807